Trial Profile
A Study of Capecitabine In Combination With Docetaxel Vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 19 Aug 2005 New trial record.